Pacific Biosciences of California, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Pacific Biosciences of California, Inc. (PACB) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.55 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-02-26
- Pacific Biosciences of California, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $10.68M, a 60.07% increase year-over-year.
- Pacific Biosciences of California, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $4.88M, a 55.06% decline year-over-year.
- Pacific Biosciences of California, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$42.59M.
- Pacific Biosciences of California, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $25.48M.
- Pacific Biosciences of California, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$1.55M.
- Pacific Biosciences of California, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$14.86M, a 272.72% decline from fiscal 2015.
- Pacific Biosciences of California, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $8.61M, a 56.01% decline from fiscal 2014.
- Pacific Biosciences of California, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $19.56M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-12-31 | $10.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $15.56M derived: sum of 2 quarters · filed 2018-02-26 | -$27.03M derived: sum of 3 quarters · filed 2018-02-26 | -$1.55M 10-K · filed 2018-02-26 |
| 2017-09-30 | $4.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$37.71M derived: sum of 2 quarters · filed 2017-11-02 | -$12.23M 10-Q · filed 2017-11-02 | -$5.56M derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-06-30 | -$42.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$17.11M 10-Q · filed 2017-08-02 | -$10.44M derived: sum of 3 quarters · filed 2018-02-26 | $425.00K derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-03-31 | $25.48M 10-Q · filed 2017-05-05 | $32.15M derived: sum of 2 quarters · filed 2018-02-26 | $43.02M derived: sum of 3 quarters · filed 2018-02-26 | $33.86M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-12-31 | $6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $17.54M derived: sum of 2 quarters · filed 2018-02-26 | $8.38M derived: sum of 3 quarters · filed 2018-02-26 | -$14.86M 10-K · filed 2018-02-26 |
| 2016-09-30 | $10.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.71M derived: sum of 2 quarters · filed 2017-11-02 | -$21.54M 10-Q · filed 2017-11-02 | -$43.97M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | -$9.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$32.40M 10-Q · filed 2017-08-02 | -$54.83M derived: sum of 3 quarters · filed 2018-02-26 | -$40.26M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | -$23.24M 10-Q · filed 2017-05-05 | -$45.67M derived: sum of 2 quarters · filed 2018-02-26 | -$31.10M derived: sum of 3 quarters · filed 2018-02-26 | -$29.93M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | -$22.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$7.86M derived: sum of 2 quarters · filed 2018-02-26 | -$6.69M derived: sum of 3 quarters · filed 2018-02-26 | $8.61M 10-K · filed 2018-02-26 |
| 2015-09-30 | $14.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $15.74M derived: sum of 2 quarters · filed 2016-11-04 | $31.04M 10-Q · filed 2016-11-04 | $29.53M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $16.47M 10-Q · filed 2016-08-04 | $14.96M derived: sum of 3 quarters · filed 2017-03-06 | $27.66M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $15.30M 10-Q · filed 2016-05-05 | $13.79M derived: sum of 2 quarters · filed 2017-03-06 | $26.49M derived: sum of 3 quarters · filed 2017-03-06 | $26.66M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $11.19M derived: sum of 2 quarters · filed 2017-03-06 | $11.37M derived: sum of 3 quarters · filed 2017-03-06 | $19.56M 10-K · filed 2017-03-06 |
| 2014-09-30 | $12.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $12.88M derived: sum of 2 quarters · filed 2015-11-05 | $21.07M 10-Q · filed 2015-11-05 | -$3.08M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $179.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $8.38M 10-Q · filed 2015-08-05 | -$15.78M derived: sum of 3 quarters · filed 2016-03-11 | -$12.01M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $8.20M 10-Q · filed 2015-05-05 | -$15.95M derived: sum of 2 quarters · filed 2016-03-11 | -$12.19M derived: sum of 3 quarters · filed 2016-03-11 | |
| 2013-12-31 | -$24.15M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$20.39M derived: sum of 2 quarters · filed 2016-03-11 | -$33.12M 10-K · filed 2016-03-11 | |
| 2013-09-30 | $3.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$8.96M 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | -$12.73M 10-Q · filed 2014-08-05 | |||
| 2012-12-31 | $61.79M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |